Table 2.
Comparison of SARS-CoV-2 specific IgG responses ([log2(FI)]) between survivors and nonsurivivors.
| Proteins | All | Survivors | Nonsurvivors | p |
|---|---|---|---|---|
| S1 | 13.9(13.0–14.4) | 13.9(13.0–14.4) | 13.6(12.0–14.6) | 0.3 |
| S2 | 9.1(8.4–9.6) | 9.1(8.4–9.6) | 9.0(8.1–9.7) | 0.34 |
| N | 10.3(9.2–11.1) | 10.3(9.2–11.2) | 9.8(7.9–10.6) | <0.001 |
| N-Nter | 13.2(12.3–13.8) | 13.2(12.3–13.8) | 13.1(11.6–13.7) | 0.1 |
| N-Cter | 13.4(12.5–14.0) | 13.4(12.6–14.0) | 13.3(11.8–14.2) | 0.68 |
| E | 5.5(4.6–6.8) | 5.5(4.6–6.8) | 5.8(4.9–7.6) | 0.04 |
| NSP1 | 8.2(7.5–9.1) | 8.1(7.4–9.0) | 9.0(8.4–9.6) | <0.001 |
| NSP2 | 6.6(5.6–7.8) | 6.5(5.6–7.7) | 7.1(6.0–8.2) | 0.01 |
| NSP4 | 7.9(7.4–8.7) | 7.9(7.3–8.7) | 8.2(7.8–9.4) | <0.001 |
| NSP5 | 5.5(4.9–6.2) | 5.5(4.9–6.2) | 5.8(5.1–6.7) | 0.01 |
| NSP7 | 9.4(8.8–10.0) | 9.4(8.8–10.0) | 9.9(9.6–10.4) | <0.001 |
| NSP8 | 7.8(6.8–9.0) | 7.6(6.7–8.9) | 8.8(8.0–9.2) | <0.001 |
| NSP9 | 8.7(8.0–9.5) | 8.7(8.0–9.5) | 9.4(8.6–9.8) | <0.001 |
| NSP10 | 6.3(5.3–7.6) | 6.2(5.3–7.4) | 7.2(6.5–8.0) | <0.001 |
| RdRp | 8.1(7.4–9.3) | 8.0(7.4–9.2) | 9.2(8.5–9.6) | <0.001 |
| NSP14 | 7.4(6.7–8.4) | 7.3(6.6–8.3) | 8.3(7.7–9.1) | <0.001 |
| NSP15 | 7.1(6.2–8.4) | 7.1(6.1–8.3) | 7.7(6.6–9.1) | 0.02 |
| NSP16 | 7.1(6.3–8.2) | 7.0(6.3–8.2) | 7.7(6.6–8.9) | 0.004 |
| ORF3a | 5.2(4.0–6.6) | 5.3(4.0–6.6) | 4.6(3.4–5.7) | 0.001 |
| ORF3b | 8.7(8.0–9.6) | 8.6(8.0–9.6) | 9.6(9.1–9.9) | <0.001 |
| ORF6 | 3.7(0.0–4.9) | 3.7(0.0–4.9) | 3.4(0.0–4.7) | 0.3 |
| ORF7b | 6.4(5.4–7.2) | 6.4(5.5–7.2) | 5.6(4.8–6.8) | <0.001 |
| ORF9b | 8.0(7.5–8.8) | 8.0(7.4–8.7) | 8.4(7.9–9.5) | <0.001 |
FI: Fluorescence Intensity. Mann-Whitney U test was conducted to test difference between survivor and nonsurvivor groups.